Latest Top 40, page-24

My view is a cash injection is unnecessary at the moment.

There is plenty of cash in bank, stock in warehouses, R&D refund due soon, revenue from iqbuds and presales of Boost flowing in, etc)

If the opportunity to tap the investor market was taken, as you suggest, i reckon it would come in the form of a placement offered at a premium to investors that recognise the value of nuhera and who know they wouldnt get a nice slice on market at a better price.

There is absolutely no need for nuhera to sell itself short anymore.

And Id welcome any such placement. It'd put an even bigger rocket under the share price. Itd demonstrate a strong conviction of support and acknowledgement of value plus bring in exta cash to accelerate production and advertising.